(Q43592584)

25 November 2017

Collapsin response mediator protein 2 is involved in regulating breast cancer progression (English)

1 reference

25 November 2017

Kazuhiro Shimada

1

1 reference

25 November 2017

Takashi Ishikawa

2

1 reference

25 November 2017

Fumio Nakamura

3

1 reference

25 November 2017

Daisuke Shimizu

4

1 reference

25 November 2017

Takashi Chishima

5

1 reference

25 November 2017

Yasushi Ichikawa

6

1 reference

25 November 2017

Takeshi Sasaki

7

1 reference

25 November 2017

Itaru Endo

8

1 reference

25 November 2017

Yoji Nagashima

9

1 reference

25 November 2017

Yoshio Goshima

10

1 reference

25 November 2017

5 February 2013

1 reference

25 November 2017

1 reference

25 November 2017

21

1 reference

25 November 2017

6

1 reference

25 November 2017

715-723

1 reference

https://scigraph.springernature.com/pub.10.1007/s12282-013-0447-5

25 November 2017

0 references

cites work

Breast cancer statistics, 2011.

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

The CRMP family of proteins and their role in Sema3A signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Identification and characterization of a retinoic acid-regulated human homologue of the unc-33-like phosphoprotein gene (hUlip) from neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Tubulin and CRMP-2 complex is transported via Kinesin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Alpha2-chimaerin, cyclin-dependent Kinase 5/p35, and its target collapsin response mediator protein-2 are essential components in semaphorin 3A-induced growth-cone collapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Collapsin response mediator proteins (CRMPs) are a new class of microtubule-associated protein (MAP) that selectively interacts with assembled microtubules via a taxol-sensitive binding interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Neurofibrillary tangle-associated collapsin response mediator protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, and Ser-522

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

High expression of atypical protein kinase C lambda/iota in gastric cancer as a prognostic factor for recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Cell cycle regulatory protein 5 (Cdk5) is a novel downstream target of ERK in carboplatin induced death of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Selection of adjuvant chemotherapy for treatment of node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

How Taxol stabilises microtubule structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Triple-negative breast cancer: therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Microtubule Associated Protein (MAP)-Tau: a novel mediator of paclitaxel sensitivity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

The role of Tau protein in resistance to paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

CRMP-2 induces axons in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

The overexpression and altered localization of the atypical protein kinase C λ/ι in breast cancer correlates with the pathologic type of these tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0447-5

10.1007/S12282-013-0447-5

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference